Table 1.
Summary of selected 5 publications from East Asian and 3 from Western countries in the therapeutic drug monitoring of risperidone.
Authors, Published Year (Country, n) | Risperidone/ 9-Hydroxyrisperidone Ratio |
Active Moiety ng/mL/mg |
---|---|---|
Heykants et al. [31], 1994 (N. America, 178) | 0.22 | 9.1 |
Lee et al. [32], 1999 (Singapore, 20) | 0.24 | 8.6 |
Lane et al. [34], 2000 (Taiwan, 31) | 0.19 | 9.5 |
Spina et al. [33], 2001 (Italy, 42) | 0.14 | 9.3 |
Mihara et al. [35], 2003 (Japan, 85) | 0.11 | 6.6 |
Chen et al. [36], 2004 (Taiwan, 10) | 0.33 | 6.8 |
Riedel et al. [37], 2005 (Germany, 82) | 0.40 | 10.7 |
Yasui-Furukori et al. [38], 2010 (Japan, 51) | 0.14 | 7.3 |
Total (Mean ± SD) | 0.22 ± 0.10 | 8.5 ±1.5 |
Ease Asian Mean (Mean ± SD) | 0.23 ± 0.08 | 8.1 ± 1.2 |
Western Mean (Mean ± SD) | 0.22 ± 0.13 | 8.9 ± 1.7 |